Filling the need for trusted information on national health issues…

Vaccines

  • Your Selections:

Refine Results

date

Tags

Clinical Trial Testing Hookworm Vaccine To Begin In Gabon Next Year

“The first African clinical trial of an experimental vaccine against hookworm is planned for next year,” the New York Times reports. Though rarely fatal, the worms are especially a concern among children who often go barefoot, the newspaper notes, adding, “By constantly draining their victims’ blood, the worms cause anemia,…

IAVI, Partners Working To Prevent ‘Brain Drain’ In Developing Countries

In a guest post on the Global Health Technologies Coalition’s (GHTC) “Breakthroughs” blog, Elisabeth Wilhelm, senior media specialist at the International AIDS Vaccine Initiative (IAVI), “writes about the need to invest in the next generation of researchers and scientists in sub-Saharan Africa,” according to the introduction. “Access to quality education…

GAVI Alliance Releases Mid-Term Review

The GAVI Alliance released its 2013 Mid-Term Review, which reports on the organization’s 2011-2015 strategy. The report, including an overview and sections on results, challenges, prospects and key indicators, is available online (October 2013).

Editorials Address Prospect Of Malaria Vaccine

“The Sixth Pan African Multilateral Initiative on Malaria, the world’s largest conference on malaria, took place in Durban, South Africa, [last] week, where results from the most clinically advanced trials showed that over 18 months of follow-up, the RTS,S vaccine almost halved the number of malaria cases in young children…

Experts Say Rabies Kills 24,000 People Annually In Africa

“Rabies kills 24,000 people a year in Africa, most of them children, because many on the world’s poorest continent cannot afford the cost of the vaccine, experts said on Thursday” at a conference of rabies experts held in Dakar, Reuters reports. “Africa is home to nearly half the 55,000 people…

‘Science Speaks’ Features Several Posts On AIDS Vaccine 2013 Conference

The Center for Global Health Policy’s “Science Speaks” blog features a series of blog posts on issues discussed at the AIDS Vaccine 2013 conference that recently concluded in Barcelona. The blog includes a post discussing the need to include married or cohabitating couples in HIV prevention trials; a post discussing next…

Innovation, Partnership Necessary To Bring Vaccines To The Poor

Noting the WHO this week endorsed a new Chinese-produced Japanese encephalitis vaccine, Bill Gates, co-chair of the Bill & Melinda Gates Foundation writes in the organization’s “Impatient Optimists” blog, “[T]here’s a powerful story here about the tremendous progress the world is making to save and improve the lives of the…

Experts React To GSK’s Planned Filing For Approval Of Malaria Vaccine

“Experts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution on Tuesday to news that the first vaccine against the killer disease may soon reach the market,” Agence France-Presse reports. “GlaxoSmithKline said it was seeking approval for a prototype vaccine that reduced the risk of malaria…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.